Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. [electronic resource]
Producer: 20120627Description: 73-6 p. digitalISSN:- 1872-8332
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- diagnostic imaging
- Chemoradiotherapy -- methods
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Fluorodeoxyglucose F18 -- pharmacokinetics
- Humans
- Lung Neoplasms -- diagnostic imaging
- Middle Aged
- Positron-Emission Tomography -- methods
- Prospective Studies
- Radiopharmaceuticals -- pharmacokinetics
- Radiotherapy Planning, Computer-Assisted
- Tomography, X-Ray Computed -- methods
- Tumor Burden -- radiation effects
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.